Search results
Fauci agrees to testify in Congress on COVID origins, pandemic policies
Stars and Stripes· 6 days agoFauci has agreed to testify in front of the House panel investigating the nation’s coronavirus...
Antimicrobial Resistance as Risk Factor for Recurrent Bacteremia after Staphylococcus aureus, ...
Centers for Disease Control and Prevention· 4 days agoAntimicrobial Resistance after Bacteremia
Patients with Long COVID May Tolerate Cautious Exercise Rehabilitation
Journal of the American Medical Association· 4 days agoAn estimated 17 million people in the US alone currently have post-COVID condition (PCC), also known...
New toolkit makes molecular dynamics simulations more accessible
Phys.org· 7 days agoThe crux of this method consists of running multiple MD simulations in parallel, thereby exploring...
Quantum Computing Meets Genomics: The Dawn of Hyper-Fast DNA Analysis
SciTechDaily· 6 days agoA new project unites world-leading experts in quantum computing and genomics to develop new methods...
RedHill Announces First Patient Enrolled in U.S. Government-Supported COVID-19 Study
FOX 23 News Albany· 6 days agoRALEIGH, N.C. and TEL-AVIV, Israel, April 24, 2024 /PRNewswire/ -- RedHill Biopharma Ltd. (Nasdaq: RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company, today announced ...
NIH RECOVER Makes Long COVID Data Easier to Access - Deidentified Data from Thousands of Adults with...
Sierra Sun Times· 4 days agoDeidentified data from thousands of adults with long COVID are now available to researchers. April...
Should You Worry About The Bird Flu? Here Are The Concerns
Forbes· 3 days agoYou may have heard the recent revelations that the H5N1 bird flu virus has been spreading among...
A National Security Insider Does the Math on the Dangers of AI
Wired News· 7 days agoIn 2002, the first virus was synthesized from scratch on a Darpa project, and it was sort of an “oh...
Trinity Biotech (NASDAQ:TRIB) Coverage Initiated at StockNews.com
ETF DAILY NEWS· 4 days agoResearch analysts at StockNews.com initiated coverage on shares of Trinity Biotech (NASDAQ:TRIB – Get Free Report) in a research report issued on Wednesday. The firm set a “buy” rating on the ...